Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).
Bertoli S, Bérard E, Peterlin P, Guieze R, Desbrosses Y, Hicheri Y, Benbrahim O, Carre M, Orvain C, Banos A, Bernard M, Gyan E, Saad A, Chebrek S, Guepin GR, Dorvaux V, Sanhes L, Gallego-Hernanz MP, Exbrayat C, Vincent L, Himberlin C, Simand C, Vey N, Fenoll C, Mineur A, Huynh A, Vergez F, Luquet I, Largeaud L, Delabesse E, Pigneux A, Récher C.
Bertoli S, et al. Among authors: fenoll c.
Haematologica. 2025 Oct 1;110(10):2475-2480. doi: 10.3324/haematol.2024.286807. Epub 2025 Feb 6.
Haematologica. 2025.
PMID: 39911128
Free PMC article.
No abstract available.